Literature DB >> 25790089

3'RR targeting in lymphomagenesis: a promising strategy?

Alexis Saintamand1, Faten Saad, Yves Denizot.   

Abstract

Year:  2015        PMID： 25790089      PMCID： PMC4613984          DOI： 10.1080/15384101.2015.1010964

Source DB:  PubMed          Journal:  Cell Cycle        ISSN： 1551-4005            Impact factor:   4.534


× No keyword cloud information.
  7 in total

1.  Genomic deletion of the whole IgH 3' regulatory region (hs3a, hs1,2, hs3b, and hs4) dramatically affects class switch recombination and Ig secretion to all isotypes.

Authors:  Christelle Vincent-Fabert; Remi Fiancette; Eric Pinaud; Véronique Truffinet; Nadine Cogné; Michel Cogné; Yves Denizot
Journal:  Blood       Date:  2010-06-10       Impact factor: 22.113

2.  Regulatory elements in the immunoglobulin heavy chain gene 3'-enhancers induce c-myc deregulation and lymphomagenesis in murine B cells.

Authors:  Jinghong Wang; Linda M Boxer
Journal:  J Biol Chem       Date:  2005-02-01       Impact factor: 5.157

3.  Diverse chemicals including aryl hydrocarbon receptor ligands modulate transcriptional activity of the 3'immunoglobulin heavy chain regulatory region.

Authors:  Rebecca A Henseler; Eric J Romer; Courtney E W Sulentic
Journal:  Toxicology       Date:  2009-03-31       Impact factor: 4.221

4.  The 3' IgH locus control region is sufficient to deregulate a c-myc transgene and promote mature B cell malignancies with a predominant Burkitt-like phenotype.

Authors:  Véronique Truffinet; Eric Pinaud; Nadine Cogné; Barbara Petit; Laurence Guglielmi; Michel Cogné; Yves Denizot
Journal:  J Immunol       Date:  2007-11-01       Impact factor: 5.422

5.  Mantle cell lymphoma-like lymphomas in c-myc-3'RR/p53+/- mice and c-myc-3'RR/Cdk4R24C mice: differential oncogenic mechanisms but similar cellular origin.

Authors:  Pauline Rouaud; Rémi Fiancette; Christelle Vincent-Fabert; Virginie Magnone; Michel Cogné; Pierre Dubus; Yves Denizot
Journal:  Oncotarget       Date:  2012-05

6.  The IgH 3' regulatory region controls somatic hypermutation in germinal center B cells.

Authors:  Pauline Rouaud; Christelle Vincent-Fabert; Alexis Saintamand; Rémi Fiancette; Marie Marquet; Isabelle Robert; Bernardo Reina-San-Martin; Eric Pinaud; Michel Cogné; Yves Denizot
Journal:  J Exp Med       Date:  2013-07-01       Impact factor: 14.307

7.  Targeting the oncogene B lymphoma deregulator IgH 3' regulatory region does not impede the in vivo inflammatory response in mice.

Authors:  Faten Saad; Alexis Saintamand; Pauline Rouaud; Yves Denizot
Journal:  Oncoscience       Date:  2014-09-19
  7 in total
  4 in total

1.  Eμ and 3'RR transcriptional enhancers of the IgH locus cooperate to promote c-myc-induced mature B-cell lymphomas.

Authors:  Nour Ghazzaui; Hussein Issaoui; Mélissa Ferrad; Claire Carrion; Jeanne Cook-Moreau; Yves Denizot; François Boyer
Journal:  Blood Adv       Date:  2020-01-14

2.  The IgH 3' regulatory region influences lymphomagenesis in Igλ-Myc mice.

Authors:  Faten Saad; Alexis Saintamand; Michel Cogné; Yves Denizot
Journal:  Oncotarget       Date:  2015-08-21

3.  Efficient role of IgH 3' regulatory region deficient B-cells in the development of oil granulomas.

Authors:  Nour Ghazzaui; Alexis Saintamand; Hussein Issaoui; Faten Saad; Yves Denizot
Journal:  Oncotarget       Date:  2016-06-21

Review 4.  The IgH 3' regulatory region and c-myc-induced B-cell lymphomagenesis.

Authors:  Nour Ghazzaui; Alexis Saintamand; Hussein Issaoui; Christelle Vincent-Fabert; Yves Denizot
Journal:  Oncotarget       Date:  2017-01-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.